The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An observational study of a team management approach for first-line XELOX therapy in patients with advanced/recurrent colorectal cancer: The SMILE study (the study of metastatic colorectal cancer to investigate impact of learning effect).
 
Michio Nakamura
Honoraria - Chugai Pharma; Takeda; Yakult Honsha
Consulting or Advisory Role - Bayer
Speakers' Bureau - Chugai Pharma; Sanofi
 
HIroshi Matsuoka
No Relationships to Disclose
 
Yoshihisa Shibata
No Relationships to Disclose
 
Yoshinori Munemoto
No Relationships to Disclose
 
Hiroyuki Okuda
Speakers' Bureau - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Takeda
 
Hiroshi Uchida
No Relationships to Disclose
 
Yutaka Ogata
No Relationships to Disclose
 
Genichi Nishimura
Speakers' Bureau - Chugai Pharma; Yakult Honsha
 
Takeru Shiroiwa
No Relationships to Disclose
 
Junji Kishimoto
No Relationships to Disclose
 
Kotaro Maeda
No Relationships to Disclose